Author

Yoko Koga

Institution: Toray Industries, Inc. (Japan)

Observed institution: Toray Industries, Inc. (Japan)

ORCID: 0000-0002-0908-7718

Observed ORCID: 0000-0002-0908-7718

OpenAlex ID: A5015395732

Biocompatibility of Polysulfone Hemodialysis Membranes and Its Mechanisms: Involvement of Fibrinogen and Its Integrin Receptors in Activation of Platelets and Neutrophils

2018 · Yoko Koga, Hiroaki Fujieda, et al. · Artificial Organs · 97

A new hydrophilic polysulfone hemodialysis membrane can prevent platelet–neutrophil interactions and successive neutrophil activation

2019 · Yoko Koga, Hiroyuki Meguro, et al. · The International Journal of Artificial Organs · 24

Anti-IL-12/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis

2018 · Takehiro Takahashi, Yoko Koga, et al. · European Journal of Pharmacology · 18

Design and synthesis of novel p38α MAP kinase inhibitors: Discovery of pyrazole-benzyl ureas bearing 2-molpholinopyrimidine moiety

2012 · Tadamasa Arai, Michihiro Ohno, et al. · Bioorganic & Medicinal Chemistry Letters · 14

TXB-001, A Newly-Developed Polymer-Conjugated Anthracycline, Alleviates Anthracycline-Induced Cardiotoxicity

2025 · Miki Nonaka, Mikito Hirakata, et al. · Cardiovascular Toxicology · 1

Possible Clinical Effects of Polymyxin B-Immobilized Fiber Columns via Platelet-Derived Lipid Mediators: A Prospective Observational Study

2026 · Shintaro Suzuki, Satoshi Kazuma, et al. · Blood Purification

Removal of activated neutrophils by a polymyxin B-immobilized fiber (PMX) column

2026 · Yohei Miyamoto, Ayuka Suzuki, et al. · The International Journal of Artificial Organs

Removal capacity of activated neutrophils by polymyxin B immobilized fiber (PMX) column

2025 · Yohei Miyamoto, Ayuka Suzuki, et al. · European Respiratory Journal

Abstract 679: TXB-001 is an upgraded conjugated anthracycline that targets tumors with reduced risk of cardiotoxicity, hand-foot syndrome and alopecia

2024 · Keiyu Oshida, Mikito Hirakata, et al. · Cancer Research

Inhibitory effects of an orally active small molecule alpha4beta1/alpha4beta7 integrin antagonist, TR-728, on TNBS-induced colitis in rats

2018 · Rie Sasaki, Yoko Koga, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society

Inhibitory effects of an orally active small molecule alpha4beta1/alpha4beta7 integrin antagonist, TR-728, on DSS-induced experimental colitis in mice and spontaneous colitis in HLA-B27 transgenic rats

2018 · Yoko Koga, Rie Sasaki, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society

Mo1706 Inhibitory Effects of an Orally Active Small Molecule Alpha4beta1/ Alpha4beta7 Integrin Antagonist, TRK-170, on Spontaneous Colitis in HLAB27 Transgenic Rats

2014 · Hiroe Hirokawa, Yoko Koga, et al. · Gastroenterology

Works count: 12

Citation count: 154

H-index: 4

I10-index: 4